Caligan Partners in the Press
Oct 22, 2024 - caligan partners presents verona Pharma (VRNA) at best idea conference, sees undervalued blockbuster potential in copd
JUNE 24, 2024 – ALIMERA SCIENCES (alim) IS ACQUIRED BY ani PHARMACEUTICALS (ANIP) FOR $5.50/SHARE PLUS cvr
June 1, 2023 - David Johnson of Caligan partners joins the board of exelixis (Exel)
May 17, 2023 - Caligan leads preferred equity pipe into alimera sciences (ALIM) to facilitate the purchase of the u.s. rights to yutiq from eyepoint pharmaceuticals (eypt)